Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data

BACKGROUND: There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC patients with long-term survival. This study develops a prognostic model using real world data to assist clinicians to predict survival beyond 24 months. METHODS: EGFR mutated stage IIIB and IV NSCLC patients diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Lourdes, Royuela, Ana, Carcereny, Enric, López-Castro, Rafael, Rodríguez-Abreu, Delvys, Massuti, Bartomeu, González-Larriba, José Luis, García-Campelo, Rosario, Bosch-Barrera, Joaquim, Guirado, María, Camps, Carlos, Dómine, Manuel, Bernabé, Reyes, Casal, Joaquín, Oramas, Juana, Ortega, Ana Laura, Sala, Mª. Angeles, Padilla, Airam, Aguiar, David, Juan-Vidal, Oscar, Blanco, Remei, del Barco, Edel, Martínez-Banaclocha, Natividad, Benítez, Gretel, de Vega, Blanca, Hernández, Ainhoa, Saigi, Maria, Franco, Fernando, Provencio, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406921/
https://www.ncbi.nlm.nih.gov/pubmed/34465283
http://dx.doi.org/10.1186/s12885-021-08713-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406921/
https://www.ncbi.nlm.nih.gov/pubmed/34465283
http://dx.doi.org/10.1186/s12885-021-08713-8

Ejemplares similares